Evidence-Based Results
Measurable Clinical Improvements
- Reduction in fasting glucose & HbA1c
- Stabilization of TSH levels
- Normalization of lipid profile & Triglycerides
- Improved liver enzymes (ALT/AST)
- Resolution of chronic bloating and reflux
- Measurable increase in stamina and strength
Clinical Marker
Baseline
6 Months
HbA1c (%)
7.2 (High)
5.4 (Optimal)
Fasting Insulin (uIU/mL)
24.5 (High)
6.8 (Normal)
TSH (mIU/L)
8.4 (High)
2.1 (Normal)
Triglycerides (mg/dL)
210 (High)
115 (Normal)
ALT / Liver Enzyme
58 (High)
24 (Optimal)